HomeDMYD-B • STO
add
Diamyd Medical AB
Nakaraang pagsara
kr 18.16
Sakop ng araw
kr 17.88 - kr 18.70
Sakop ng taon
kr 7.65 - kr 25.00
Market cap
1.83B SEK
Average na Volume
226.52K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Ago 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 19.00K | -74.32% |
Gastos sa pagpapatakbo | 51.15M | 40.41% |
Net na kita | -49.74M | -32.60% |
Net profit margin | -261.79K | -416.43% |
Kita sa bawat share | — | — |
EBITDA | -50.48M | -40.02% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Ago 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 132.37M | 3.79% |
Kabuuang asset | 217.04M | 5.46% |
Kabuuang sagutin | 71.12M | 95.32% |
Kabuuang equity | 145.92M | — |
Natitirang share | 104.09M | — |
Presyo para makapag-book | 12.44 | — |
Return on assets | -55.84% | — |
Return on capital | -76.10% | — |
Cash Flow
Net change in cash
| (SEK) | Ago 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -49.74M | -32.60% |
Cash mula sa mga operasyon | -29.16M | 15.53% |
Cash mula sa pag-invest | 18.79M | 886.03% |
Cash mula sa financing | -838.00K | -100.97% |
Net change in cash | -10.27M | -120.46% |
Malayang cash flow | -18.28M | 27.58% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
28
